Thermal effects on cephalopod energy metabolism - A case study for Sepia officinalis

Cephalopods are the largest, most active invertebrates and there is considerable evidence for their convergent evolution with fishes. However, most active cephalopods display standard and active metabolic rates that are several-fold higher than comparably sized fishes. Shifting habitat temperatures due to climate change will therefore affect a cephalopods energy metabolism much more than that of a fish. Prediction of the probable outcome of cephalopod-fish competition thus requires quantitative information concerning whole animal energetics and corresponding efficiencies. Migrating cephalopods such as squid and cuttlefish grow rapidly to maturity, carry few food reserves and have little overlap of generations. This "live fast, die young" life history strategy means that they require niches capable of sustaining high power requirements and rapid growth. This presentation aims to draw a bottom-up picture of the cellular basis of energy metabolism of the cuttlefish Sepia officinalis, from its molecular basis to whole animal energetics based on laboratory experiments and field data. We assessed the proportionality of standard vs active metabolic rate and the daily energetic requirements using field tracking data in combination with lab based respirometry and video analysis. Effects of environmental temperature on mitochondrial energy coupling were investigated in whole animals using in vivo 31P-NMR spectroscopy. As efficient energy turnover needs sufficient oxygen supply, also thermal effects on the blood oxygen-binding capacities of the respiratory pigment haemocyanin and the differential expression of its isoforms were investigated.Supported by NERC grant NERC/A/S/2002/00812

The Phase Diagram and Spectrum of Gauge-Fixed Abelian Lattice Gauge Theory

We consider a lattice discretization of a covariantly gauge-fixed abelian gauge theory. The gauge fixing is part of the action defining the theory, and we study the phase diagram in detail. As there is no BRST symmetry on the lattice, counterterms are needed, and we construct those explicitly. We show that the proper adjustment of these counterterms drives the theory to a new type of phase transition, at which we recover a continuum theory of (free) photons. We present both numerical and (one-loop) perturbative results, and show that they are in good agreement near this phase transition. Since perturbation theory plays an important role, it is important to choose a discretization of the gauge-fixing action such that lattice perturbation theory is valid. Indeed, we find numerical evidence that lattice actions not satisfying this requirement do not lead to the desired continuum limit. While we do not consider fermions here, we argue that our results, in combination with previous work, provide very strong evidence that this new phase transition can be used to define abelian lattice chiral gauge theories.Comment: 42 pages, 30 figure

Shocks in unmagnetized plasma with a shear flow: Stability and magnetic field generation

A pair of curved shocks in a collisionless plasma is examined with a two-dimensional particle-in-cell (PIC) simulation. The shocks are created by the collision of two electron-ion clouds at a speed that exceeds everywhere the threshold speed for shock formation. A variation of the collision speed along the initially planar collision boundary, which is comparable to the ion acoustic speed, yields a curvature of the shock that increases with time. The spatially varying Mach number of the shocks results in a variation of the downstream density in the direction along the shock boundary. This variation is eventually equilibrated by the thermal diffusion of ions. The pair of shocks is stable for tens of inverse ion plasma frequencies. The angle between the mean flow velocity vector of the inflowing upstream plasma and the shock's electrostatic field increases steadily during this time. The disalignment of both vectors gives rise to a rotational electron flow, which yields the growth of magnetic field patches that are coherent over tens of electron skin depths.Comment: 10 pages, 10 figures accepted for publication in Physics of Plasma

Monoclonal gammopathy after intense induction immunosuppression in renal transplant patients

Objectives. Incidence and risk factors of post-transplant monoclonal gammopathy were studied in renal transplant patients who received their grafts between 1982 and 1992 (n=390 grafts). Immunoelectrophoresis was performed at annual intervals after transplantation. Results. Forty-six cases of clonal gammopathy were detected: 35 monoclonal, 11 bi- or triclonal, with a predominance of IgG and K light-chain subtypes (IgG, 39; IgA, 3; IgM, 4; K, 35; λ, 19). Gammopathy was transient in 17 patients (37%). The 5-year cumulative incidence of gammopathy was 10.7%, much higher than expected for a group of similar age from the general population. Thirty of the 46 gammopathies appeared within the first 2 years of transplantation. Gammopathy never progressed to multiple myeloma during follow-up (median 1 year; (range 0-10)); one patient subsequently developed Kaposi sarcoma. The 2-year incidence of gammopathy was much higher in patients transplanted in 1989-1991 (23/142) than in 1982-1988 (7/248) (P<0.0001). This coincided with the use of quadruple induction immunosuppression (cyclosporin A+azathioprine+prednisone plus either ATG-Fresenius (ATG-F) or OKT3) since 1989. The risk for acquiring gammopathy within 2 years of transplantation was 14.7% (95% CI 9.2, 20.3%) in patients receiving quadruple induction therapy, but only 3.0% (CI 1.2, 6.1%) without such therapy (P<0.0001). The risk for patients receiving quadruple immunosuppression with OKT3 was 24.5%, significantly greater than with ATG-F (11.8%, P<0.05). Discriminant analysis revealed that the type of immunosuppression, but not age or year of transplantation, were independent risk factors for gammopathy. Conclusions. Monoclonal gammopathy frequently occurs after renal transplantation. Risks are higher for patients receiving quadruple induction immunosuppression, particularly if it includes OKT3. Follow-up of these patients is warranted for the early detection of malignant transformatio

Instability tests for air-jet textured yarns

The air-jet texturing process is briefly introduced and its advantages over other texturing processes are summarized. Characteristics of air-jet textured yarns are stated with special reference to the stability of the yarns. Test methods used in industry and research to determine the "stability" or "instability" of air-jet textured yarns are critically reviewed. These methods involve different basic principles and therefore inevitably give different results. There is no consensus on a standard method. Effects of various test parameters, such as specimen length, test duration, and the alternatives of using a single yarn, a hank, or a skein as a test specimen are investigated. An improved test method is suggested as a standard instability test, and various existing methods are compared with it. Results of all the methods show similar trends for varying values of air pressure. Other yarn characteristics such as linear density, breaking elongation, and tenacity are also determined, and their indications of yarn quality are compared with the indications of instability tests. Stability test results alone provide misleading information regarding air-jet textured yarn quality

Hyperuricaemia in cyclosporin-treated patients: a GFR-related effect

Background Hyperuricaemia is a well known side-effect of cyclosporin A (CsA) treatment. The pathogenic mechanisms, however, remain controversial. There is no convincing evidence that hyperuricaemia is due to CsA-induced, impaired tubular handling of uric acid. The impact of diminished GFR in this particular context has never been investigated. Methods We prospectively studied plasma uric acid, inulin clearances, and fractional clearances of uric acid in two groups of CsA-treated patients (bone-marrow transplant patients, n=50; renal transplant patients, n=32), and one healthy control group without CsA (living related kidney donors, n=28). Bone-marrow transplant patients were examined before transplantation and 6, 12, 18, 24 months after transplantation, renal transplant patients 1 year after transplantation, and living related kidney donors before and 1 year after unilateral nephrectomy. Results After 1 year of CsA treatment, hyperuricaemia was found in 36% of bone-marrow transplant patients and in 53% of renal transplant patients. Thirty per cent of living related kidney donors were borderline hyperuricaemic 1 year after unilateral nephrectomy. The fractional clearance of uric acid, measured serially in bone-marrow transplant patients did not change significantly over time; it was, however, slightly higher during CsA treatment than after CsA withdrawal. Moreover, the bone-marrow transplant patients' fractional clearance of uric acid was not statistically different from the renal transplant patients' and the living related kidney donors' (values 1 year after transplantation/unilateral nephrectomy: bone-marrow transplant patients, 15.3±2.3%; renal transplant patients, 11.9±0.9%; living related kidney donors, 11.1±0.8%). The GFR at 1 year, measured by inulin clearance, was identical in the CsA-treated groups and slightly higher in the living related kidney donors (bone-marrow transplant patients, 51±6 ml/min per 1.73 m2 renal transplant patients, 49±3 ml/min per 1.73 m2 living related kidney donors, 61±2 ml/min per 1.73 min2). Conclusions There is no evidence for impaired tubular handling of uric acid, induced by a CsA-specific tubulotoxic effect. Hyperuricaemia in CsA-treated transplant patients can therefore be attributed to the cyclosporin associated decrease of GF

High-rate GPS clock corrections from CODE: support of 1Hz applications

GPS zero-difference applications with a sampling rate up to 1Hz require corresponding high-rate GPS clock corrections. The determination of the clock corrections in a full network solution is a time-consuming task. The Center for Orbit Determination in Europe (CODE) has developed an efficient algorithm based on epoch-differenced phase observations, which allows to generate high-rate clock corrections within reasonably short time (<2h) and with sufficient accuracy (on the same level as the CODE rapid or final clock corrections, respectively). The clock determination procedure at CODE and the new algorithm is described in detail. It is shown that the simplifications to speed up the processing are not causing a significant loss of accuracy for the clock corrections. The high-rate clock corrections have in essence the same quality as clock corrections determined in a full network solution. In order to support 1Hz applications 1-s clock corrections would be needed. The computation time, even for the efficient algorithm, is not negligible, however. Therefore, we studied whether a reduced sampling is sufficient for the GPS satellite clock corrections to reach the same or only slightly inferior level of accuracy as for the full 1-s clock correction set. We show that high-rate satellite clock corrections with a spacing of 5s may be linearly interpolated resulting in less than 2% degradation of accurac

Excellent uricosuric efficacy of benzbromarone in cyclosporin-A-treated renal transplant patients: a prospective study

Patients on cyclosporin A (CsA) often develop hyperuricaemia and gout. In transplant patients the use of uricosuric drugs for treating hyperuricaemia may be preferable to allopurinol because of the known interaction of the latter with azathioprine. We therefore prospectively studied the uricosuric efficacy of 100 mg benzbromarone (Bbr;Desuric®) daily in 25 CsA-treated renal transplant patients with stable graft function and hyperuricaemia (>359 μmol/l for females, >491 μmol/l for males). Benzbromarone decreased plasma uric acid from 579±18 μmol/l to 313±24 μmol/l (mean±SEM; P25 ml/min. Due to its excellent efficacy and lack of significant side-effects, benzbromarone appears to be preferable to allopurinol in CsA-treated renal transplant recipients with a creati nine clearance over 25 ml/mi